Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Failure to Implement Physician-Approved Pharmacy Recommendation for Medication Reduction

Kaufman, Texas Survey Completed on 01-07-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a resident's drug regimen was free from unnecessary medications, specifically regarding the administration of Omeprazole, a proton pump inhibitor (PPI). The resident, who had multiple diagnoses including atherosclerotic heart disease, diabetes mellitus, dementia, osteoporosis, dysphagia, major depressive disorder, hypertension, and gout, had been receiving Omeprazole 40 mg daily since admission. Pharmacy recommendations dated 12/04/2025 advised decreasing the Omeprazole dose to 20 mg daily due to risks associated with long-term use, and the physician agreed to this recommendation on 12/10/2025. However, review of the medication administration record showed that the resident continued to receive the higher 40 mg dose, indicating the physician-approved pharmacy recommendation was not implemented. Interviews with nursing staff and administration revealed that the process for updating medication orders based on pharmacy recommendations involved the DON and ADON, who were responsible for reviewing, processing, and entering new orders once approved by the physician. Despite this established process, the recommended change was not made, and staff were unable to explain why the order was not updated. The facility's policy on handling unnecessary medications or pharmacy recommendations was requested but not provided during the survey. The administrator acknowledged responsibility for ensuring that pharmacy recommendations, once approved by the physician, are implemented and monitored by nursing administration.

An unhandled error has occurred. Reload 🗙